Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 3
1948 1
1949 3
1950 2
1951 2
1952 4
1953 2
1954 1
1955 3
1956 4
1957 3
1958 2
1959 3
1960 1
1961 5
1962 4
1963 11
1964 23
1965 26
1966 22
1967 23
1968 31
1969 44
1970 38
1971 47
1972 55
1973 57
1974 73
1975 96
1976 80
1977 93
1978 73
1979 82
1980 107
1981 98
1982 86
1983 135
1984 155
1985 143
1986 138
1987 157
1988 158
1989 147
1990 182
1991 167
1992 223
1993 216
1994 184
1995 212
1996 268
1997 257
1998 278
1999 331
2000 362
2001 348
2002 344
2003 386
2004 395
2005 410
2006 477
2007 498
2008 525
2009 543
2010 676
2011 668
2012 762
2013 824
2014 859
2015 793
2016 773
2017 794
2018 837
2019 874
2020 1006
2021 1089
2022 1081
2023 1007
2024 398

Text availability

Article attribute

Article type

Publication date

Search Results

18,995 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Urinary bladder neurofibroma"
Page 1
Application of nanotechnology in the diagnosis and treatment of bladder cancer.
Xu Y, Luo C, Wang J, Chen L, Chen J, Chen T, Zeng Q. Xu Y, et al. J Nanobiotechnology. 2021 Nov 27;19(1):393. doi: 10.1186/s12951-021-01104-y. J Nanobiotechnology. 2021. PMID: 34838048 Free PMC article. Review.
For example, gold nanoparticles (AuNPs) have been developed for simple, fast and sensitive urinary sample test for bladder cancer diagnosis. Nanoparticles targeting bladder cancers can facilitate to distinguish the normal and abnormal bladder tissues d …
For example, gold nanoparticles (AuNPs) have been developed for simple, fast and sensitive urinary sample test for bladder can …
Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer.
Lai H, Cheng X, Liu Q, Luo W, Liu M, Zhang M, Miao J, Ji Z, Lin GN, Song W, Zhang L, Bo J, Yang G, Wang J, Gao WQ. Lai H, et al. Int J Cancer. 2021 Dec 15;149(12):2099-2115. doi: 10.1002/ijc.33794. Epub 2021 Sep 16. Int J Cancer. 2021. PMID: 34480339 Free article.
Bladder cancer represents a highly heterogeneous disease characterized by distinct histological, molecular and clinical phenotypes, and a detailed analysis of tumor cell invasion and crosstalks within bladder tumor cells has not been determined. ...Ove …
Bladder cancer represents a highly heterogeneous disease characterized by distinct histological, molecular and clinical phenotypes, a …
Editorial comment.
Kamat AM, Gontero P. Kamat AM, et al. Curr Opin Urol. 2018 Nov;28(6):555-556. doi: 10.1097/MOU.0000000000000551. Curr Opin Urol. 2018. PMID: 30256260 No abstract available.
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review.
Soorojebally Y, Neuzillet Y, Roumiguié M, Lamy PJ, Allory Y, Descotes F, Ferlicot S, Kassab-Chahmi D, Oudard S, Rébillard X, Roy C, Lebret T, Rouprêt M, Audenet F. Soorojebally Y, et al. World J Urol. 2023 Feb;41(2):345-359. doi: 10.1007/s00345-022-04253-3. Epub 2023 Jan 2. World J Urol. 2023. PMID: 36592175 Review.
Current research focuses on diagnostic biomarkers that could improve bladder cancer detection and follow-up by discriminating patients at risk of aggressive cancer who need confirmatory TURBT (Transurethral Resection of Bladder Tumour) from patients at no ris …
Current research focuses on diagnostic biomarkers that could improve bladder cancer detection and follow-up by discriminating patient …
Molecular classification of urothelial bladder carcinoma.
Schwarzova L, Varchulova Novakova Z, Danisovic L, Ziaran S. Schwarzova L, et al. Mol Biol Rep. 2023 Sep;50(9):7867-7877. doi: 10.1007/s11033-023-08689-7. Epub 2023 Jul 31. Mol Biol Rep. 2023. PMID: 37525073 Free PMC article. Review.
Urothelial bladder carcinoma (UC) ranks among the top ten most commonly diagnosed cancers worldwide on an annual basis. The standardized classification system for urothelial bladder tumors is the Tumor, Node, Metastasis classification, which reflects d …
Urothelial bladder carcinoma (UC) ranks among the top ten most commonly diagnosed cancers worldwide on an annual basis. The standardi …
Diagnosis and management of intradiverticular bladder tumours.
Walker NF, Gan C, Olsburgh J, Khan MS. Walker NF, et al. Nat Rev Urol. 2014 Jul;11(7):383-90. doi: 10.1038/nrurol.2014.131. Epub 2014 Jun 17. Nat Rev Urol. 2014. PMID: 24934450 Review.
Intradiverticular bladder tumours (IDBT) account for approximately 1% of all urinary bladder tumours. The risk of developing a tumour within a bladder diverticulum is considered to be greater than in the main bladder, possib …
Intradiverticular bladder tumours (IDBT) account for approximately 1% of all urinary bladder tumours. The …
Diagnosis and management of intradiverticular bladder tumours: A pooled analysis of 498 cases.
Katsimperis S, Tzelves L, Bellos T, Angelopoulos P, Tsikopoulos I, Mitsogiannis I, Papatsoris A. Katsimperis S, et al. Arch Ital Urol Androl. 2022 Dec 28;94(4):486-491. doi: 10.4081/aiua.2022.4.486. Arch Ital Urol Androl. 2022. PMID: 36576457 Free article. Review.
The evaluation included patient sex, age, diagnostic methods, symptoms, localization of the tumor, tumor staging, tumor histopathology, treatment, and the presence of recurrence. ...Most of the patients had cystoscopy (56.85%) and intravenous or computed tomo …
The evaluation included patient sex, age, diagnostic methods, symptoms, localization of the tumor, tumor staging, tumor …
Pediatric urothelial bladder neoplasm.
Galiya R, Stanislav K, Jawdat J, Benjamin H, Boris C. Galiya R, et al. J Pediatr Urol. 2022 Dec;18(6):833.e1-833.e4. doi: 10.1016/j.jpurol.2022.06.026. Epub 2022 Jun 30. J Pediatr Urol. 2022. PMID: 35871900
OBJECTIVES: To report our experience and long-term follow-up data on pediatric patients with urothelial carcinoma of the urinary bladder. METHODS: In this retrospective two center study, we analyzed the perioperative and long-term follow-up data of nine pediatric pa …
OBJECTIVES: To report our experience and long-term follow-up data on pediatric patients with urothelial carcinoma of the urinary b …
Magnetic resonance imaging of bladder pheochromocytomas: a review.
Zulia Y, Gopireddy D, Virarkar MK, Morani AC, Adimula P, Kumar S, Bhosale P, Lall C. Zulia Y, et al. Abdom Radiol (NY). 2022 Dec;47(12):4032-4041. doi: 10.1007/s00261-022-03483-8. Epub 2022 Mar 28. Abdom Radiol (NY). 2022. PMID: 35347385 Review.
Bladder pheochromocytomas (PCCs) are rare tumors that account for 0.06% of all bladder tumors and makeup 1% of all PCCs. ...We also discuss how MRI can differentiate bladder PCCs from other bladder neoplasms....
Bladder pheochromocytomas (PCCs) are rare tumors that account for 0.06% of all bladder tumors and makeup 1% of a …
Blood-based protein biomarkers in bladder urothelial tumors.
López-Cortés R, Gómez BB, Vázquez-Estévez S, Pérez-Fentes D, Núñez C. López-Cortés R, et al. J Proteomics. 2021 Sep 15;247:104329. doi: 10.1016/j.jprot.2021.104329. Epub 2021 Jul 21. J Proteomics. 2021. PMID: 34298186 Review.
An adequate TURBT requires complete resection of all visible tumour with appropriate sampling of the bladder to assess the depth of invasion. However, for many years, researchers have attempted to identify and utilise urinary markers for bladder cancer …
An adequate TURBT requires complete resection of all visible tumour with appropriate sampling of the bladder to assess the dep …
18,995 results
You have reached the last available page of results. Please see the User Guide for more information.